Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

EU approves first-line use of AZ’ Tagrisso in lung cancer

pharmatimesJuly 10, 2018

Tag: AstraZeneca , Osimertinib , lung cancer , NSCLC

PharmaSources Customer Service